Target Medicals Group Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Series A
- Investors
-
5
Target Medicals Group General Information
Description
Developer of therapeutic drugs designed to treat a range of medical conditions. The company's platform offers aldosterone synthase inhibitors and drug development programs targeting infectious diseases, enabling healthcare providers and researchers to treat hormone-related conditions and drug-resistant infections.
Contact Information
Website
target-medicals.comCorporate Office
- Mysliborska 85
- Warsaw, 05-077
- Poland
Corporate Office
- Mysliborska 85
- Warsaw, 05-077
- Poland
Target Medicals Group Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series A) | 29-Dec-2025 | Completed | Pre-Clinical Trials | |||
| 3. Later Stage VC (Series 1) | 01-Feb-2022 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 09-Oct-2017 | $190K | $190K | Completed | Pre-Clinical Trials | |
| 1. Grant | 01-Jan-2016 | $86.8K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Target Medicals Group Patents
Target Medicals Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026197933-A1 | Compounds having antimycobacterial activity | Pending | 18-Mar-2025 | ||
| WO-2019190354-A1 | Phenylformamidine derivatives having antimycobacterial activity | Inactive | 29-Mar-2018 |
Target Medicals Group Signals
Target Medicals Group Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AstraZeneca | Corporation | Minority | ||
| Russian Direct Investment Fund | Sovereign Wealth Fund | Minority | ||
| Unicorn Capital Partners | Venture Capital | Minority | ||
| Skolkovo Foundation | Limited Partner | |||
| Startup Village | Government |
Target Medicals Group FAQs
-
When was Target Medicals Group founded?
Target Medicals Group was founded in 2015.
-
Where is Target Medicals Group headquartered?
Target Medicals Group is headquartered in Warsaw, Poland.
-
What is the size of Target Medicals Group?
Target Medicals Group has 7 total employees.
-
What industry is Target Medicals Group in?
Target Medicals Group’s primary industry is Drug Discovery.
-
Is Target Medicals Group a private or public company?
Target Medicals Group is a Private company.
-
What is Target Medicals Group’s current revenue?
The current revenue for Target Medicals Group is .
-
How much funding has Target Medicals Group raised over time?
Target Medicals Group has raised $190K.
-
Who are Target Medicals Group’s investors?
AstraZeneca, Russian Direct Investment Fund, Unicorn Capital Partners, Skolkovo Foundation, and Startup Village have invested in Target Medicals Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process